Travere Therapeutics, Inc. (TVTX)
42.88
+0.31
(+0.73%)
USD |
NASDAQ |
May 18, 15:59
Travere Therapeutics Total Liabilities (Quarterly) : 456.46M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 753.82M |
| AbbVie, Inc. | 143.08B |
| Mirum Pharmaceuticals, Inc. | 648.42M |
| Anika Therapeutics, Inc. | 45.49M |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 555.19M |
| Shareholders Equity (Quarterly) | 98.73M |
| Debt to Equity Ratio | 3.319 |
| Current Ratio | 3.130 |
| Net Debt Paydown Yield | 0.54% |